The Pancreatic and Biliary Stents Market study analyzes and forecasts the market size across 6 regions and 24 countries for diverse segments- By Product (Plastic Stents, Metal Stents), By Application (Benign Biliary Structures, Bili-Pancreatic Leakages, Pancreatic Cancer, Others), By End-User (Hospitals, Ambulatory Surgical Centers, Others).
In 2024, the market for pancreatic and biliary stents continues to witness growth, driven by the increasing prevalence of pancreaticobiliary disorders such as pancreatic cancer, bile duct obstruction, and pancreaticobiliary strictures, as well as advancements in endoscopic and interventional techniques for managing these conditions. Pancreatic and biliary stents are specialized medical devices used to maintain patency and facilitate drainage of the pancreatic duct and biliary tract in patients with obstructive lesions or strictures, enabling relief of symptoms such as jaundice, abdominal pain, and pancreatitis. These stents are available in various designs, including plastic stents, metal stents, and biodegradable stents, each tailored to specific clinical indications and anatomical considerations. The market for pancreatic and biliary stents encompasses both traditional endoscopic placement techniques and advanced interventional radiology procedures, with a focus on improving stent design, durability, and compatibility with imaging modalities to optimize patient outcomes and minimize complications. Technological advancements in pancreatic and biliary stents include the development of fully covered self-expanding metal stents (FCSEMS) with anti-migration features, drug-eluting stents for preventing stent-related complications, and magnetic resonance-compatible stents for enhanced visualization during imaging studies. Moreover, the integration of endoscopic ultrasound (EUS)-guided stenting, digital cholangioscopy, and robotic-assisted interventions enables precise stent placement, comprehensive tissue evaluation, and minimally invasive treatment options for complex pancreaticobiliary diseases. With the growing demand for minimally invasive procedures, multidisciplinary approaches, and personalized treatment strategies in pancreaticobiliary care, the market for pancreatic and biliary stents is poised for continued expansion, offering patients and healthcare providers innovative solutions for managing pancreatic and biliary disorders and improving quality of life.
A prominent trend in the Pancreatic and Biliary Stents market is the increasing adoption of minimally invasive procedures, which is driving the demand for stents. As healthcare providers and patients seek alternatives to traditional open surgeries, minimally invasive techniques such as endoscopic retrograde cholangiopancreatography (ERCP) and percutaneous transhepatic cholangiography (PTC) are becoming increasingly prevalent for the management of pancreatic and biliary disorders. Stents play a crucial role in these procedures by providing temporary or permanent relief of obstructions, facilitating drainage, and maintaining patency of the pancreatic and biliary ducts. The shift towards minimally invasive approaches not only reduces patient morbidity and recovery times but also creates a growing market for pancreatic and biliary stents, as they are essential components of these procedures.
A primary driver fueling the growth of the Pancreatic and Biliary Stents market is the rising incidence of pancreatic and biliary disorders worldwide. Conditions such as pancreatic cancer, bile duct stones, pancreatitis, and strictures are becoming increasingly prevalent due to factors such as aging populations, changes in lifestyle habits, and the rising prevalence of risk factors such as obesity and alcohol consumption. These disorders often lead to obstructive jaundice, biliary obstruction, and other complications that require interventions such as stent placement to alleviate symptoms and improve patient outcomes. The growing disease burden underscores the critical need for effective treatment options, including pancreatic and biliary stents, driving market demand and fostering innovations in stent technology and design.
An emerging opportunity in the Pancreatic and Biliary Stents market lies in the development of biodegradable stents. While traditional metal and plastic stents are effective in providing temporary relief of obstructions, they may pose long-term risks such as stent occlusion, tissue ingrowth, and stent-related complications. Biodegradable stents offer a promising alternative by providing temporary support and then gradually degrading and resorbing within the body over time, eliminating the need for stent removal procedures and reducing the risk of long-term complications. The development of biodegradable stents represents an opportunity for innovation and differentiation within the market, as these devices have the potential to improve patient outcomes, reduce healthcare costs, and enhance the overall safety and efficacy of pancreatic and biliary interventions. Collaborations between medical device manufacturers, research institutions, and healthcare providers are essential to capitalize on this opportunity and bring biodegradable stent technologies to market, addressing unmet clinical needs and driving advancements in pancreatic and biliary care.
Among the various products and applications in the pancreatic and biliary stents market, metal stents for pancreatic cancer are experiencing rapid growth. Pancreatic cancer often presents with biliary obstruction due to tumor compression or invasion of the bile ducts. Metal stents, including self-expandable metallic stents (SEMS), are commonly used to relieve biliary obstruction and improve drainage in patients with pancreatic cancer. Metal stents offer several advantages over plastic stents, including greater durability, larger luminal diameter, and longer patency duration, making them the preferred choice for palliative management of malignant biliary strictures. With the increasing incidence of pancreatic cancer and the growing adoption of minimally invasive endoscopic procedures for stent placement, the demand for metal stents for pancreatic cancer is on the rise. Additionally, advancements in stent design and deployment techniques have improved the safety and efficacy of metal stent placement, further contributing to their growing utilization in clinical practice. As healthcare providers prioritize the management of biliary obstruction in patients with pancreatic cancer and seek durable and effective stent solutions, the market for metal stents for pancreatic cancer is expected to witness significant growth.
The market research study provides in-depth insights into leading companies including the SWOT analyses, product profile, financial details, and recent developments acrossAbbott Laboratories, B. Braun Melsungen AG, Becton, Dickinson and Company, Boston Scientific Corp, Cardinal Health, CONMED Corp, Cook Medical Inc, End-Flex GmbH, Medtronic Plc, Olympus Corp, Stryker Corp, Taewoong Medical Co. Ltd
By Product
Plastic Stents
Metal Stents
By Application
Benign Biliary Structures
Bili-Pancreatic Leakages
Pancreatic Cancer
Others
By End-User
Hospitals
Ambulatory Surgical Centers
Others
Geographical Analysis
North America (United States, Canada, Mexico)
Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)
Abbott Laboratories
B. Braun Melsungen AG
Becton, Dickinson and Company
Boston Scientific Corp
Cardinal Health
CONMED Corp
Cook Medical Inc
End-Flex GmbH
Medtronic Plc
Olympus Corp
Stryker Corp
Taewoong Medical Co. Ltd
• Deepen your industry insights and navigate uncertainties for strategy formulation, CAPEX, and Operational decisions
• Gain access to detailed insights on the Pancreatic and Biliary Stents Market, encompassing current market size, growth trends, and forecasts till 2030.
• Access detailed competitor analysis, enabling competitive advantage through a thorough understanding of market players, strategies, and potential differentiation opportunities
• Stay ahead of the curve with insights on technological advancements, innovations, and upcoming trends
• Identify lucrative investment avenues and expansion opportunities within the Pancreatic and Biliary Stents Market industry, guided by robust, data-backed analysis.
• Understand regional and global markets through country-wise analysis, regional market potential, regulatory nuances, and dynamics
• Execute strategies with confidence and speed through information, analytics, and insights on the industry value chain
• Corporate leaders, strategists, financial experts, shareholders, asset managers, and governmental representatives can make long-term planning scenarios and build an integrated and timely understanding of market dynamics
• Benefit from tailored solutions and expert consultation based on report insights, providing personalized strategies aligned with specific business needs.
TABLE OF CONTENTS
1 Introduction to 2024 Pancreatic and Biliary Stents Market
1.1 Market Overview
1.2 Quick Facts
1.3 Scope/Objective of the Study
1.4 Market Definition
1.5 Countries and Regions Covered
1.6 Units, Currency, and Conversions
1.7 Industry Value Chain
2 Research Methodology
2.1 Market Size Estimation
2.2 Sources and Research Methodology
2.3 Data Triangulation
2.4 Assumptions and Limitations
3 Executive Summary
3.1 Global Pancreatic and Biliary Stents Market Size Outlook, $ Million, 2021 to 2030
3.2 Pancreatic and Biliary Stents Market Outlook by Type, $ Million, 2021 to 2030
3.3 Pancreatic and Biliary Stents Market Outlook by Product, $ Million, 2021 to 2030
3.4 Pancreatic and Biliary Stents Market Outlook by Application, $ Million, 2021 to 2030
3.5 Pancreatic and Biliary Stents Market Outlook by Key Countries, $ Million, 2021 to 2030
4 Market Dynamics
4.1 Key Driving Forces of Pancreatic and Biliary Stents Industry
4.2 Key Market Trends in Pancreatic and Biliary Stents Industry
4.3 Potential Opportunities in Pancreatic and Biliary Stents Industry
4.4 Key Challenges in Pancreatic and Biliary Stents Industry
5 Market Factor Analysis
5.1 Value Chain Analysis
5.2 Competitive Landscape
5.2.1 Global Pancreatic and Biliary Stents Market Share by Company (%), 2023
5.2.2 Product Offerings by Company
5.3 Porter’s Five Forces Analysis
5.4 Pricing Analysis and Outlook
6 Growth Outlook Across Scenarios
6.1 Growth Analysis-Case Scenario Definitions
6.2 Low Growth Scenario Forecasts
6.3 Reference Growth Scenario Forecasts
6.4 High Growth Scenario Forecasts
7 Global Pancreatic and Biliary Stents Market Outlook by Segments
7.1 Pancreatic and Biliary Stents Market Outlook by Segments, $ Million, 2021- 2030
By Product
Plastic Stents
Metal Stents
By Application
Benign Biliary Structures
Bili-Pancreatic Leakages
Pancreatic Cancer
Others
By End-User
Hospitals
Ambulatory Surgical Centers
Others
8 North America Pancreatic and Biliary Stents Market Analysis and Outlook To 2030
8.1 Introduction to North America Pancreatic and Biliary Stents Markets in 2024
8.2 North America Pancreatic and Biliary Stents Market Size Outlook by Country, 2021-2030
8.2.1 United States
8.2.2 Canada
8.2.3 Mexico
8.3 North America Pancreatic and Biliary Stents Market size Outlook by Segments, 2021-2030
By Product
Plastic Stents
Metal Stents
By Application
Benign Biliary Structures
Bili-Pancreatic Leakages
Pancreatic Cancer
Others
By End-User
Hospitals
Ambulatory Surgical Centers
Others
9 Europe Pancreatic and Biliary Stents Market Analysis and Outlook To 2030
9.1 Introduction to Europe Pancreatic and Biliary Stents Markets in 2024
9.2 Europe Pancreatic and Biliary Stents Market Size Outlook by Country, 2021-2030
9.2.1 Germany
9.2.2 France
9.2.3 Spain
9.2.4 United Kingdom
9.2.4 Italy
9.2.5 Russia
9.2.6 Norway
9.2.7 Rest of Europe
9.3 Europe Pancreatic and Biliary Stents Market Size Outlook by Segments, 2021-2030
By Product
Plastic Stents
Metal Stents
By Application
Benign Biliary Structures
Bili-Pancreatic Leakages
Pancreatic Cancer
Others
By End-User
Hospitals
Ambulatory Surgical Centers
Others
10 Asia Pacific Pancreatic and Biliary Stents Market Analysis and Outlook To 2030
10.1 Introduction to Asia Pacific Pancreatic and Biliary Stents Markets in 2024
10.2 Asia Pacific Pancreatic and Biliary Stents Market Size Outlook by Country, 2021-2030
10.2.1 China
10.2.2 India
10.2.3 Japan
10.2.4 South Korea
10.2.5 Indonesia
10.2.6 Malaysia
10.2.7 Australia
10.2.8 Rest of Asia Pacific
10.3 Asia Pacific Pancreatic and Biliary Stents Market size Outlook by Segments, 2021-2030
By Product
Plastic Stents
Metal Stents
By Application
Benign Biliary Structures
Bili-Pancreatic Leakages
Pancreatic Cancer
Others
By End-User
Hospitals
Ambulatory Surgical Centers
Others
11 South America Pancreatic and Biliary Stents Market Analysis and Outlook To 2030
11.1 Introduction to South America Pancreatic and Biliary Stents Markets in 2024
11.2 South America Pancreatic and Biliary Stents Market Size Outlook by Country, 2021-2030
11.2.1 Brazil
11.2.2 Argentina
11.2.3 Rest of South America
11.3 South America Pancreatic and Biliary Stents Market size Outlook by Segments, 2021-2030
By Product
Plastic Stents
Metal Stents
By Application
Benign Biliary Structures
Bili-Pancreatic Leakages
Pancreatic Cancer
Others
By End-User
Hospitals
Ambulatory Surgical Centers
Others
12 Middle East and Africa Pancreatic and Biliary Stents Market Analysis and Outlook To 2030
12.1 Introduction to Middle East and Africa Pancreatic and Biliary Stents Markets in 2024
12.2 Middle East and Africa Pancreatic and Biliary Stents Market Size Outlook by Country, 2021-2030
12.2.1 Saudi Arabia
12.2.2 UAE
12.2.3 Oman
12.2.4 Rest of Middle East
12.2.5 Egypt
12.2.6 Nigeria
12.2.7 South Africa
12.2.8 Rest of Africa
12.3 Middle East and Africa Pancreatic and Biliary Stents Market size Outlook by Segments, 2021-2030
By Product
Plastic Stents
Metal Stents
By Application
Benign Biliary Structures
Bili-Pancreatic Leakages
Pancreatic Cancer
Others
By End-User
Hospitals
Ambulatory Surgical Centers
Others
13 Company Profiles
13.1 Company Snapshot
13.2 SWOT Profiles
13.3 Products and Services
13.4 Recent Developments
13.5 Financial Profile
List of Companies
Abbott Laboratories
B. Braun Melsungen AG
Becton, Dickinson and Company
Boston Scientific Corp
Cardinal Health
CONMED Corp
Cook Medical Inc
End-Flex GmbH
Medtronic Plc
Olympus Corp
Stryker Corp
Taewoong Medical Co. Ltd
14 Appendix
14.1 Customization Offerings
14.2 Subscription Services
14.3 Related Reports
14.4 Publisher Expertise
By Product
Plastic Stents
Metal Stents
By Application
Benign Biliary Structures
Bili-Pancreatic Leakages
Pancreatic Cancer
Others
By End-User
Hospitals
Ambulatory Surgical Centers
Others
Countries Analyzed
North America (United States, Canada, Mexico)
Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)
The global Pancreatic and Biliary Stents Market is one of the lucrative growth markets, poised to register a 5.9% growth (CAGR) between 2024 and 2030.
Emerging Markets across Asia Pacific, Europe, and Americas present robust growth prospects.
Abbott Laboratories, B. Braun Melsungen AG, Becton, Dickinson and Company, Boston Scientific Corp, Cardinal Health, CONMED Corp, Cook Medical Inc, End-Flex GmbH, Medtronic Plc, Olympus Corp, Stryker Corp, Taewoong Medical Co. Ltd
Base Year- 2023; Estimated Year- 2024; Historic Period- 2018-2023; Forecast period- 2024 to 2030; Currency: USD; Volume